Occurrence of Selected Generic Drugs 3

Project Title Occurrence of Selected Generic Drugs 3
Date Posted
Thursday, December 13, 2012
Project ID
MSY2_STR102-103
Status
Complete
Deliverables
Description

Summary table assessment of the use of Alosetron hydrochloride (HCL), Ambrisentan, Bosentan, Buprenorphine HCL, Buprenorphine HCL/Naloxone HCL, Fentanyl, Hydromorphone HCL, Isotretinoin, Lenalidomide, Methadone HCL, Morphine sulfate, Oxycodone HCL, Rosiglitazone Maleate, Rosiglitazone/Glimepiride, Rosiglitazone/Metformin HCL, and Thalidomide. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.Summary tables are precompiled stratified counts. Queries were executed in September 2011. This report includes data from 15 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
alosetron HCL
ambrisentan
bosentan
buprenorphine HCL
fentanyl
hydromorphone HCL
isotretinoin
lenalidomide
methadone HCL
morphine sulfate
naloxone HCL
oxycodone HCL
rosiglitazone maleate
rosiglitazone/glimepiride
rosiglitazone/metformin HCL
thalidomide
Time Period
2000 - 2010
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER